Table 1. Characteristics of the participants.
| Placebo n = 65 |
HCQ n = 62 |
All subjects n = 127 |
|
|---|---|---|---|
| Age (median (interquartile range)) | 31.9 (27.2–43.7) | 31.0 (26.4–39) | 31.1 (26.6–40.3) |
| Male gender (%) | 23 (35.4) | 33 (57.4) | 56 (42.52) |
| Days of exposition to COVID-19 (median (interquartile range)) | 47 (28–64) | 40 (26–64) | 41 (26–64) |
| Profession (% physicians or nurses) | 33 (50.8) | 31 (50) | 64 (50.39) |
| Number with night shifts (%) | 17 (26.2) | 24 (35.5) | 39 (30.7) |
| Working at another medical center (%) | 18 (27.7) | 16 (25.8) | 34 (26.8) |
| Presence of concomitant disease (%) | 7 (10.8) | 9 (14.5) | 16 (12.6) |
| Previous or active smoking (%) | 23 (35.4) | 20 (32.3) | 43 (33.9) |
| Number reporting > 1 alcohol drink a week (%) | 8 (12.5) | 12 (19.4) | 20 (15.9) |
| Body mass index (kg/m2) (mean (standard deviation)) | 27.2 (4.6) | 26.7 (3.9) | 27.0 (4.3) |
| Obesity (%) | 15 (23.1) | 9 (11.3) | 24 (18.5) |
| Use of other medications (%) | 30 (46.2) | 43 (69.4) | 73 (57.5) |